How to Sell a Contract Manufacturing Business in 2026: Multiples, Customer Concentration, and the Value-Added Margin Reality

Selling a contract manufacturing business in 2026 is structurally different from selling a metal fabricator, machine shop, or precision shop. Contract manufacturing carries unique valuation dynamics: pass-through material revenue distorts headline metrics, customer concentration is structurally higher than other manufacturing sub-verticals (CMOs by nature serve fewer, larger customers), supply chain dependencies are more pronounced, and quality systems are scrutinized more rigorously by buyers. The result is a buyer pool that values scale, OEM relationships, and operational discipline — but discounts heavily for concentration risk.

This guide is for contract manufacturing owners with $5M-$200M of revenue and $750K-$15M of normalized earnings. Contract manufacturing typically operates at scale — sub-$5M revenue contract manufacturers are unusual because the relationship economics don’t support smaller operations. We’ll walk through the actual buyer pool at this size, the multiples you should realistically expect, the customer concentration math that dominates valuation, the pass-through vs value-added margin distinction critical for proper valuation, the quality systems requirements (ISO 9001 minimum, ISO 13485 for medical CMOs, AS9100D for aerospace CMOs, IATF 16949 for automotive CMOs), supply chain resilience, and the 18-24 month preparation playbook that materially improves outcomes.

The framework draws on direct work with 76+ active U.S. lower middle market buyers, 38 of which are explicitly pursuing manufacturing platforms and add-ons. We’re a buy-side partner. The buyers pay us when a deal closes — not you. That includes industrial PE platforms specifically active in contract manufacturing (Audax Private Equity industrial verticals, KKR Industrials, Cortec Group / Bromford Industries, Trive Capital, GenNx360, Wynnchurch Capital, Sterling Group industrial), strategic CMO consolidators (Jabil, Celestica, Sanmina, Flex, Kimball Electronics for electronics; Integer Holdings, MTD Micro Molding, Bel Fuse for medical; private industrial CMO platforms), family offices with industrial mandates, and selective search funder activity. The point isn’t to convince you to sell — it’s to give you an honest read on what selling a contract manufacturing business actually looks like in 2026.

One realistic note before you start. If you’ve seen a competitor sell for “7x EBITDA on $80M revenue” and you’re running similar revenue, the math you’re running is almost certainly wrong without understanding the value-added vs pass-through breakdown. That competitor likely had: customer top-3 below 40%; top customer below 20%; ISO 9001 + IATF 16949 (or ISO 13485 / AS9100D depending on end market); long-term supply agreements with major OEMs; supply chain resilience (dual-sourced critical inputs); and value-added margin reported separately from pass-through. Headline multiples in trade press describe these platform-quality businesses — not the $50M revenue CMO with one Tier 1 automotive OEM at 60% concentration that operates on quarterly POs without long-term agreements.

“The mistake most contract manufacturing owners make is reporting on headline revenue and headline EBITDA without separating pass-through material cost from value-added margin. Buyers don’t pay multiples on pass-through revenue. They pay on value-added EBITDA — and your customer concentration risk is the gating constraint on what multiple they’ll apply. The right answer is a buy-side partner who already knows the industrial PE buyers and CMO consolidators, not a broker selling them a process.”

Key Takeaways

• Realistic multiples: $750K-$2M EBITDA = 4.5-6x; $2M-$5M EBITDA = 5-6.5x; $5M-$15M EBITDA = 5.5-7.5x; $15M+ EBITDA platforms = 6.5-9x. Customer concentration top customer above 30% subtracts 0.5-1.5 turns. Industry certifications (ISO 13485, AS9100D, IATF 16949) add 0.5-1.5 turns.
• Customer concentration is the #1 multiple-killer. Top customer above 30% = significant discount (0.5-1.5x EBITDA). Top-3 customers above 50% = significant discount. Below 20% top customer + diversified top-3 = no discount and often premium.
• Pass-through revenue vs value-added margin: 40-70% of CMO revenue is typically pass-through material cost. Buyers underwrite on value-added EBITDA, not headline revenue. Report value-added separately to enable proper valuation.
• Quality systems and certifications drive multiples: ISO 9001 baseline expected; ISO 13485 for medical device CMOs adds 1-1.5x; AS9100D for aerospace CMOs adds 1-2x; IATF 16949 for automotive CMOs adds 0.5-1x; FDA registration for medical CMOs adds 0.5x; ITAR for defense CMOs adds 0.5-1x.
• Supply chain resilience: dual-sourcing critical inputs, geographic diversification of supply base, sub-tier supplier qualification. Buyers since 2020 have demanded supply chain resilience explicitly — sole-sourced critical inputs are a 0.25-0.5x EBITDA discount.
• Active 2026 buyers: Audax Private Equity industrial verticals (very active in CMO), KKR Industrials, Cortec Group / Bromford Industries, Trive Capital, GenNx360, Industrial Growth Partners (IGP), Wynnchurch Capital, plus strategic CMO consolidators (Jabil, Celestica, Sanmina, Flex, Kimball Electronics, Integer Holdings, Bel Fuse).

Why contract manufacturing is structurally different from other manufacturing M&A

Contract manufacturing occupies a unique spot in the manufacturing M&A spectrum. Larger scale than typical job shops (CMOs typically run $20M-$200M revenue with 100-1,500 employees). Higher customer concentration (CMOs by nature serve fewer, larger customers — the relationship economics support 5-15 major customers, not 200). More complex pass-through revenue dynamics (raw material is 40-70% of revenue and flows through with markup). Supply chain dependencies are more pronounced because the customer specifies materials, components, and processes. Quality systems are scrutinized more rigorously because the customer is putting their brand on the product.

The valuation math depends on isolating value-added margin. A contract manufacturer with $80M revenue and $7M EBITDA where 60% is pass-through material is actually a $32M value-added business with $7M EBITDA — a 22% value-added EBITDA margin. The same $80M revenue / $7M EBITDA business with only 30% pass-through material is a $56M value-added business with $7M EBITDA — a 12.5% value-added EBITDA margin. Both have $7M reported EBITDA but they’re fundamentally different businesses from a valuation perspective. Buyers underwrite on value-added economics, not headline revenue.

What this means for contract manufacturing sellers in 2026. The 2026 buyer pool for contract manufacturing is sophisticated and looks closely at customer concentration, value-added margin, supply chain resilience, and quality systems before pricing a deal. Audax Private Equity industrial verticals is one of the most active CMO buyers in LMM PE. KKR Industrials pursues larger CMO platforms. Cortec Group’s Bromford Industries platform actively bolts on industrial CMOs. Trive Capital and GenNx360 selectively pursue industrial CMOs. Strategic CMO consolidators (Jabil, Celestica, Sanmina, Flex for electronics; Integer Holdings, Bel Fuse for medical) buy at platform scale ($50M+ revenue). Owners with diversified customer bases, certification stacks, and supply chain resilience routinely receive 5-10 IOIs from sophisticated buyers.

Who actually buys contract manufacturing businesses in 2026: the five archetypes

The contract manufacturing buyer pool divides into five archetypes, each with materially different motivations, multiples, and deal structures. Knowing which archetype fits your business is the single highest-leverage positioning decision. A $1M EBITDA industrial CMO marketed as if Audax would buy it wastes 9 months — Audax targets are typically $5M+ EBITDA. A $20M EBITDA aerospace CMO platform with AS9100D + ITAR + diversified customer base marketed only to regional consolidators leaves $30-60M on the table.

Archetype 1: Industrial PE platforms specifically active in CMO. Audax Private Equity industrial verticals (one of the most active CMO buyers in LMM PE), KKR Industrials, Cortec Group / Bromford Industries, Trive Capital, GenNx360, Wynnchurch Capital, Sterling Group industrial. Typical target: $5M-$30M EBITDA contract manufacturers with ISO 9001 minimum (industry-specific certs preferred), diversified customer base, real plant management, and end-market exposure to growing sectors. Multiples: 6-8x EBITDA on platforms, 5-6.5x on bolt-ons. Heavy preference for cash + 15-30% rollover equity. Close timeline: 90-180 days.

Archetype 2: Industry-specific CMO consolidators. Electronics CMOs (Jabil, Celestica, Sanmina, Flex, Kimball Electronics, Benchmark Electronics, Plexus, Sparton). Medical device CMOs (Integer Holdings, Bel Fuse, MTD Micro Molding, Phillips Medisize, Cretex Medical, Vention Medical, NDH Medical). Aerospace/defense CMOs (Heico, TransDigm, Howmet bolt-on programs, Senior Aerospace, Curtiss-Wright). Industrial CMOs (privately-held strategic platforms backed by PE). Typical target: any size where strategic fit is clear. Multiples: 5.5-9x EBITDA depending on synergy depth and end-market value.

Archetype 3: Regional industrial CMO consolidators backed by LMM PE. Regional consolidators bolting on $1M-$5M EBITDA industrial CMOs in adjacent geographies or with complementary capabilities. Multiples: 4.5-6x EBITDA. Often willing to pay slightly less than direct PE platforms but close faster (60-120 days) and offer continued employment for owners willing to stay on as plant managers.

Archetype 4: Family offices with industrial mandates. Multi-generational family money pursuing direct ownership of cash-flowing industrial businesses. Typical target: $2M-$10M EBITDA, often willing to hold longer than PE (10+ year horizon vs PE’s 5-year). Multiples: 5-7x EBITDA. Often more patient on structure, willing to roll seller equity at 25-40%, and less aggressive on retention bonuses. Close timeline: 90-180 days.

Archetype 5: Search funders (selective, with industry background). Less common in CMO than in general machine shops because the technical and operational complexity is higher and search funders without industry background struggle. Search funders with prior CMO or industrial operations experience are competitive at $1M-$3M EBITDA targets. Multiples: 4.5-6x EBITDA. Close timeline: 120-180 days.

Buyer archetype	Typical multiple	Deal structure norms	Close timeline
Industrial PE platform (Audax, KKR, Cortec/Bromford, Trive, GenNx360, Wynnchurch)	6-8x EBITDA (platform), 5-6.5x (bolt-on)	Cash + 15-30% rollover + WC adjustment	90-180 days
Industry CMO consolidator (Jabil, Celestica, Sanmina, Flex, Integer, Bel Fuse, Heico)	5.5-9x EBITDA (high variance)	Cash + earnout, retention bonuses	90-150 days
Regional CMO consolidator	4.5-6x EBITDA	Cash + 10-20% seller note, faster close	60-120 days
Family office with industrial mandate	5-7x EBITDA	Cash + 25-40% rollover, longer hold	90-180 days
Search funder (with industry background)	4.5-6x EBITDA	Senior debt + 10-20% seller note + earnout	120-180 days

Buyer type	Cash at close	Rollover equity	Exclusivity	Best fit for
Strategic acquirer	High (40–60%+)	Low (0–10%)	60–90 days	Sellers who want a clean exit; competitor or upstream consolidator
PE platform	Medium (60–80%)	Medium (15–25%)	60–120 days	Sellers willing to hold rollover for the second sale; bigger deals
PE add-on	Higher (70–85%)	Low–Medium (10–20%)	45–90 days	Sellers folding into existing platform; faster process
Search fund / ETA	Medium (50–70%)	High (20–40%)	90–180 days	Legacy-conscious sellers wanting an owner-operator successor
Independent sponsor	Medium (55–75%)	Medium (15–30%)	60–120 days	Sellers OK with deal-by-deal capital and longer financing closes

Realistic contract manufacturing multiples by size and end market: what 2026 deal data actually shows

The most common owner mistake is anchoring on multiples from articles that don’t separate pass-through revenue from value-added margin. When you see “contract manufacturers sell for 7-9x EBITDA” in trade press, that’s describing platform-quality CMOs with diversified customer bases, full certification stacks, and structural value-added margin advantages. That’s not the $40M revenue automotive Tier 2 CMO with one Tier 1 customer at 55%, ISO 9001 only (no IATF 16949), and quarterly purchase orders without long-term agreements.

$750K-$2M EBITDA: 4.5-6x EBITDA typical. Smaller CMOs sold primarily to regional consolidators, search funders with industry background, or strategic acquirers. ISO 9001 baseline expected. Customer concentration is typically very high at this size (top customer often 40-60%) which compresses multiples. Multiples improve materially with: (a) industry-specific certifications (ISO 13485 for medical, AS9100D for aerospace, IATF 16949 for automotive); (b) customer diversification efforts; (c) long-term supply agreements; (d) value-added margin reporting separated from pass-through.

$2M-$5M EBITDA: 5-6.5x EBITDA typical. Wider buyer pool kicks in: industrial PE bolt-ons, industry CMO consolidators, family offices, regional consolidators. Multiples improve materially with: (a) ISO 9001 + industry-specific certifications; (b) customer diversification (no customer above 25%); (c) long-term supply agreements with major OEMs; (d) supply chain resilience documentation; (e) real plant management; (f) end-market exposure to growing sectors (medical device, aerospace defense, industrial automation).

$5M-$15M EBITDA: 5.5-7.5x EBITDA typical. Platform territory for industrial PE specifically active in CMO. Audax Private Equity industrial verticals, KKR Industrials, Cortec Group / Bromford Industries, Trive Capital, GenNx360 all compete in this range. Multiples premium for: full certification stack (ISO 9001 + ISO 13485 / AS9100D / IATF 16949 as applicable); diversified customer base (top-3 below 40%); long-term agreements with Fortune 500 customers; supply chain resilience; tech-enabled operations (modern ERP/MES, real-time visibility); demonstrated growth through customer acquisition and program wins.

$15M+ EBITDA: 6.5-9x EBITDA typical, with strategic premium possible. Platform-of-the-platform deals. Strategic premium from industry CMO consolidators (Jabil, Celestica, Sanmina, Flex for electronics; Integer Holdings, Bel Fuse for medical; aerospace/defense strategic acquirers) paying up for proven platforms with multi-customer incumbency. Industrial PE platform exits at premium multiples to strategic acquirers. At this size, the buyer values management team, customer relationships, and certification stack as much as the EBITDA itself.

End-market premium math. Medical device CMO with ISO 13485 + FDA registration: 6-8.5x EBITDA. Aerospace/defense CMO with AS9100D + ITAR: 6.5-9x EBITDA. Automotive Tier 1/Tier 2 CMO with IATF 16949: 5-7x EBITDA (cyclical end-market discount offset by certification premium). Industrial CMO with ISO 9001 only: 5-6.5x EBITDA. Electronics CMO with IPC certifications and strategic OEM relationships: 5.5-7.5x EBITDA. End-market diversification across multiple high-premium sectors maximizes multiple.

CMO size + characteristics	EBITDA multiple range	Dominant buyer pool	Premium drivers
$750K-$2M EBITDA, ISO 9001 only	4.5-6x EBITDA	Regional consolidator, search funder, strategic	Customer diversification, long-term agreements
$2M-$5M EBITDA, ISO 9001 + industry cert	5-6.5x EBITDA	Industrial PE bolt-on, industry consolidator	End-market exposure, supply chain resilience
$5M-$15M EBITDA medical device CMO (ISO 13485 + FDA)	6-8.5x EBITDA	Audax, Integer Holdings, Bel Fuse, medical PE	FDA-cleared product history, validated processes
$5M-$15M EBITDA aerospace/defense CMO (AS9100D + ITAR)	6.5-9x EBITDA	AE Industrial, Heico, TransDigm, Senior	Program incumbency, prime relationships
$5M-$15M EBITDA industrial CMO	5.5-7.5x EBITDA	Audax, KKR Industrials, Cortec/Bromford, Trive	Customer diversification, long-term agreements
$15M+ EBITDA platform, full cert stack	6.5-9x EBITDA	Industry strategic (Jabil, Celestica, Sanmina, Flex, Integer)	Scale, multi-customer incumbency

Customer concentration: the #1 multiple-killer in contract manufacturing

Customer concentration is structurally higher in contract manufacturing than in any other manufacturing sub-vertical — and it’s the single biggest multiple compression factor. By the nature of the contract manufacturing business model, CMOs serve fewer, larger customers. The relationship economics support 5-15 major customers, not 200. Quality system audits, supplier qualification processes, customer-specific tooling, and dedicated production capacity all create switching costs that lock in concentrated customer relationships. The result is that top-3 customers are often above 40% of revenue, and the top customer alone is frequently 25-50%. Buyers will pro-forma concentration risk explicitly and discount aggressively.

Why concentration is uniquely punishing in CMO valuation. An OEM customer at 40%+ of revenue is an existential risk for the buyer. If that OEM in-sources production, dual-sources to a competitor, experiences their own demand shock (auto OEM model retirement, medical device program discontinuation, defense program cancellation), or simply renegotiates pricing aggressively, the acquired CMO loses 40%+ of revenue overnight. Unlike a job shop where 40% concentration is concerning, in CMO it’s structurally common which makes buyers even more vigilant. Buyers will pro-forma the concentrated revenue at 50-60% probability of churn over a 5-year hold and apply a discount equivalent to 1-1.5 turns of EBITDA.

Concentration thresholds buyers use in CMO. Top customer above 30% = significant discount (0.5-1.5x EBITDA). Top customer 20-30% = mild discount (0.25-0.5x). Top customer below 20% = no discount. Top-3 customers above 50% = significant discount. Top-3 customers below 40% = no discount. Buyers also examine length of relationship (a 15-year relationship with a Tier 1 OEM with multi-program incumbency is materially different from a 3-year relationship on a single program), contractual structure (purchase orders vs. long-term agreements vs. multi-year supply contracts vs. blanket POs), and end-market diversification.

Contractual structure matters as much as concentration percentages. A CMO with 50% concentration on one customer but a 5-year long-term supply agreement with rolling renewal is materially different from a CMO with 50% concentration on quarterly POs without long-term commitment. Buyers value contractual durability. Long-term agreements (LTAs), supply chain partnership agreements, and program-incumbent positions on multi-year OEM platforms (e.g., a 10-year position on a 737 program component) provide protection against concentration risk and partially offset the discount. CMO sellers should document contractual structure in the CIM proactively.

The 18-24 month diversification playbook. Aggressive new-customer acquisition focused on adjacent end markets and applications. Intentional volume reduction with the concentrated customer (counterintuitive but materially improves multiple). New industry penetration. Capacity allocation toward new customers even at modestly lower margin in year 1-2 to build the diversified base before sale. Documenting diversification trends in the CIM. Owners who execute this shift see 1-2 turns of EBITDA improvement in their final multiple — on $5M EBITDA, that’s $5-10M of additional sale price.

Pass-through revenue vs value-added margin: the valuation math that matters

Pass-through material cost vs value-added margin is the single most important reporting distinction in contract manufacturing M&A — and the most commonly mishandled by sellers. Contract manufacturing revenue typically includes 40-70% pass-through material cost. The customer specifies the materials (often the customer’s preferred suppliers), the CMO procures them, and they flow through revenue with a markup. The CMO’s actual value-add is the labor, machine time, overhead, quality systems, and program management applied on top of the materials. Buyers underwrite valuations on value-added EBITDA, not headline revenue or headline EBITDA-to-revenue ratios.

Why this matters for proper valuation. Two CMOs with $50M revenue and $5M EBITDA can be radically different businesses. CMO A: 70% pass-through material ($35M), 30% value-added revenue ($15M), $5M EBITDA = 33% value-added EBITDA margin. This is a high-quality value-added business. CMO B: 30% pass-through material ($15M), 70% value-added revenue ($35M), $5M EBITDA = 14% value-added EBITDA margin. This is a moderate-quality value-added business with thinner margins. Both report 10% reported EBITDA margin, but they’re fundamentally different. CMO A trades at premium multiple; CMO B trades at average multiple.

How to report value-added margin properly. Restructure your income statement to separate pass-through material cost from value-added components. Show: (1) gross revenue; (2) pass-through material cost (separately identified); (3) value-added revenue (gross revenue minus pass-through); (4) value-added cost of goods sold (direct labor, machine time, indirect labor); (5) value-added gross margin; (6) value-added EBITDA. This restated income statement is what sophisticated buyers will reconstruct anyway during diligence — doing it proactively in the CIM signals operational maturity and accelerates underwriting.

Value-added EBITDA margin benchmarks by end market. Industrial CMO: 15-25% value-added EBITDA margin typical. Electronics CMO: 8-15% (lower margin reflects commodity nature and price competition). Medical device CMO: 20-30% (premium reflects regulatory barriers and validated process value). Aerospace CMO: 18-28% (premium reflects certification barriers and program incumbency). Automotive Tier 1/Tier 2 CMO: 10-18% (compressed margin reflects OEM purchasing power). Higher value-added EBITDA margin = higher multiple at exit.

Material cost pass-through structure and inflation pass-through. Buyers care deeply about material cost pass-through structure because it isolates value-added margin from commodity volatility. CMOs with explicit material cost pass-through clauses in customer agreements (or material cost + markup pricing) are protected against inflation and commodity price spikes. CMOs with fixed-price contracts that don’t pass through material cost are exposed to commodity volatility. Strong pass-through (with explicit contractual indexation tied to commodity benchmarks like CRU steel price index, CME aluminum price, etc.) is multiple-neutral but verifiable. Weak pass-through is a 0.25-0.5x EBITDA discount because buyers will pro-forma future commodity volatility risk.

Component	Typical share of price	When you actually receive it	Risk to seller
Cash at close	60–80%	Wire on closing day	Low — this is real money
Earnout	10–20%	Over 18–24 months, performance-based	High — routinely paid out at less than face value
Rollover equity	0–25%	At the next platform sale (typically 4–6 years)	Variable — can multiply or go to zero
Indemnity escrow	5–12%	12–24 months after close (if no claims)	Medium — usually returned, sometimes contested
Working capital peg	+/- 2–7% of price	Adjustment at close or 30-90 days post	High — methodology disputes are common

Quality systems and certifications by end market

Quality systems and certifications are foundational to contract manufacturing M&A valuation because they signal both operational maturity and end-market access. Buyers will examine your certification stack against the end markets you serve and ensure alignment. A medical device CMO without ISO 13485 is a non-starter (regulatory blocker for FDA-cleared products). An aerospace CMO without AS9100D can’t serve aerospace primes. An automotive Tier 1 CMO without IATF 16949 can’t serve major OEMs. The certification stack determines which end markets you can serve and which buyers will pay premium multiples.

ISO 9001: the baseline expectation. ISO 9001:2015 is the broad quality management system certification expected for any serious contract manufacturer. ISO 9001 alone doesn’t add multiple but its absence subtracts — an uncertified CMO is essentially uninvestible at any meaningful scale. Annual surveillance audit cost: $5-15K. Re-certification every 3 years.

ISO 13485: the medical device CMO standard. ISO 13485:2016 is the medical-device-specific quality management standard, built on ISO 9001 with medical-device-specific requirements (design controls, validation, risk management per ISO 14971, post-market surveillance). FDA establishment registration is required for U.S. medical device manufacturing. Validated processes (IQ/OQ/PQ documentation) for FDA-cleared products. ISO 13485 + FDA registration adds 1-1.5 turns of EBITDA on medical device CMOs by opening the buyer pool to medical device-focused PE and medical OEM strategics. Certification cost: $80-200K plus 12-18 months.

AS9100D: the aerospace and defense CMO standard. AS9100D is the aerospace-specific quality management standard. Required by aerospace primes (Boeing, Lockheed Martin, Northrop Grumman, Raytheon, GE Aviation, Pratt & Whitney). NADCAP for special processes (heat treat, NDT, chemical processing). AS9102 First Article Inspection (FAI) library required. Adds 1-2 turns of EBITDA on aerospace CMOs. Certification cost: $80-200K plus 12-18 months.

IATF 16949: the automotive Tier 1/Tier 2 CMO standard. IATF 16949:2016 is the automotive-specific quality management standard, required by major automotive OEMs (Ford, GM, Stellantis, Toyota, Honda, Hyundai, BMW, Mercedes-Benz, Volkswagen) and Tier 1 suppliers. Built on ISO 9001 with automotive-specific requirements (PPAP, APQP, FMEA, MSA, SPC). Adds 0.5-1 turn of EBITDA on automotive CMOs. Certification cost: $60-150K plus 12-18 months.

ITAR + CMMC 2.0 for defense CMOs. ITAR registration ($2,250 annual fee with U.S. State Department) is mandatory for handling defense articles or controlled technical data. CMMC 2.0 (Cybersecurity Maturity Model Certification) is becoming mandatory for prime and subcontract relationships with the Department of Defense in 2026-2027. ITAR + CMMC 2.0 adds 0.5-1 turn for CMOs serving defense end market by opening the defense PE buyer pool.

Supply chain dependencies and resilience: the post-2020 buyer focus

Supply chain resilience has become a critical buyer focus in contract manufacturing M&A since 2020. The COVID-19 supply chain disruptions, semiconductor shortage, and ongoing geopolitical tensions have made buyers acutely aware of supply chain risk. CMOs with sole-sourced critical inputs, single-region supply concentrations, or weak sub-tier supplier qualification processes are discounted by 0.25-0.5x EBITDA because the buyer must pro-forma supply chain disruption risk into their underwriting.

What buyers examine in supply chain diligence. Top supplier list with concentration percentages. Geographic distribution of supply base (U.S. vs Mexico vs China vs other). Sub-tier supplier qualification documentation. Sole-sourced critical inputs identification. Dual-sourcing strategy and progress. Inventory levels (raw material, WIP, finished goods) and turnover. Lead time benchmarks. Supplier corrective action history. Supply chain risk register (post-2020 expectation). Continuity plans for critical suppliers.

Dual-sourcing strategy and qualification. Dual-sourcing critical inputs (raw materials, components, sub-assemblies) is the gold standard for supply chain resilience. Buyers want to see qualified secondary suppliers with documented qualification process, periodic test runs, and ability to ramp capacity if primary supplier fails. Dual-sourcing is expensive (qualification costs, dual inventory holding, slightly higher cost per unit) but buyers will pay premium for the resilience it provides. CMOs with documented dual-sourcing on top-10 critical inputs trade at 0.25-0.5x premium.

Geographic concentration and reshoring. CMOs with high geographic concentration in single regions (especially China for components or single Mexico facilities for sub-assembly) are discounted because buyers underwrite tariff and disruption risk. The 2026 reshoring trend has favored CMOs with U.S. and near-shore (Mexico) supply bases over deep-Asia supply concentrations. CMOs with diversified global supply (U.S. primary, Mexico secondary, Asia tertiary with documented qualification) trade at premium.

Inventory management and working capital. Contract manufacturing carries significant working capital tied up in inventory (raw material, WIP, finished goods awaiting customer pull). Buyers will examine inventory turnover (target 6-12 turns annually depending on end market and contract structure) and DPO/DIO/DSO metrics. CMOs with disciplined inventory management (LEAN principles, kanban with key suppliers, customer-managed inventory or VMI programs where appropriate) trade at premium because working capital efficiency translates directly to free cash flow.

How CMO owners should calculate value-added EBITDA for sale

Calculating value-added EBITDA properly is the most important financial reporting work an CMO seller can do before going to market. Headline EBITDA is what shows on your tax return. Value-added EBITDA is what buyers will use to underwrite multiple. The difference can be material — a $5M EBITDA CMO with high pass-through can look like either a 12% or 33% value-added EBITDA margin business depending on how it’s reported. Reporting properly maximizes valuation.

Step-by-step value-added EBITDA calculation. Start with reported EBITDA. Confirm reported revenue. Identify pass-through material cost separately (typically the largest component of COGS). Subtract pass-through material from gross revenue to get value-added revenue. Identify direct labor, machine burden, and indirect labor as value-added cost components. Calculate value-added gross margin and value-added EBITDA. Then apply standard EBITDA add-backs (owner compensation if owner-operated, one-time expenses, certification costs, ERP implementation, etc.) to get adjusted value-added EBITDA. Restate the income statement showing both views.

Owner compensation add-backs. For owner-operated CMOs (less common at $5M+ EBITDA scale but real at $1M-$5M EBITDA), apply standard SDE-to-EBITDA conversion: add owner’s W-2 salary above market rate, owner’s health insurance, family on payroll above market, country club / personal travel, owner’s vehicle, owner’s phone, owner’s discretionary perks. For CMOs already running with professional CEO/COO management, this section may be smaller.

CMO-specific add-backs buyers will accept. ISO 9001 / ISO 13485 / AS9100D / IATF 16949 audit and certification costs (one-time and partial recurring add-back during transition). FDA registration fees and process validation costs. ERP / MES implementation. CMMC 2.0 implementation costs (one-time during 2025-2027 transition). Major customer onboarding costs (PPAP / FAI / qualification runs for major new customer). Legal fees on settled commercial disputes. One-time facility expansion or relocation costs.

Add-backs buyers will reject. Cash sales not on books. Aggressive depreciation timing. Family members on payroll well above market with no operational role. Personal residence rent. Aggressive expense categorizations that don’t survive bank scrutiny or QoE. Buyers’ CPAs and Quality of Earnings firms will haircut aggressive add-backs and re-trade the deal. Aggressive add-backs on certification costs that aren’t actually one-time get partially rejected.

What buyers diligence in contract manufacturing M&A: the full checklist

Contract manufacturing diligence is among the most rigorous in the manufacturing M&A spectrum because the customer relationships, certifications, and supply chain dependencies all carry material risk. Buyers verify earnings quality with explicit value-added margin analysis, validate customer concentration and contractual structure, confirm equipment condition and capacity, assess supply chain resilience, audit certifications, examine quality systems documentation, and identify environmental, regulatory, and warranty exposure. Diligence often spans 60-150 days for $5M+ EBITDA platforms.

Earnings quality and value-added margin validation. 24-36 months of monthly P&Ls with pass-through material separately identified. Tax returns matching financials within 5%. CPA-prepared annual financial statements. Bank reconciliations. AR aging and bad debt history. Value-added margin trended monthly. Job costing reports by major customer and program. Material cost as percentage of revenue trended monthly. Direct labor as percentage of value-added revenue. Overhead absorption methodology. Standard cost vs actual cost variances.

Customer concentration, contracts, and program incumbency. Top 10 customers as percentage of revenue (concentration math, with value-added concentration calculated separately from total revenue concentration). Customer relationship tenure. Contractual structure (POs vs LTAs vs multi-year supply agreements vs blanket POs). Long-term agreement library. Program-level concentration. New customer acquisition rate over 24-36 months. Customer churn analysis. End-market diversification. Customer-specific quality requirements (PPAP, FAI, customer audits). Customer reference calls (buyers will request these on top customers).

Equipment, capacity, and capex. Major equipment list with brand, model, year, hours, original cost, current FMV. Maintenance records by machine. Replacement schedule and capex budget for next 5 years. Capacity utilization by major equipment / line. OEE trended over 24-36 months. Outstanding capital lease balances. Real estate ownership and lease terms. Production cell layouts and changeover times.

Supply chain, inventory, and working capital. Top supplier list with concentration percentages and geographic distribution. Sub-tier supplier qualification documentation. Sole-sourced critical inputs. Dual-sourcing strategy and progress. Inventory levels (raw, WIP, finished) and turnover trends. Lead time benchmarks. Supplier corrective action history. Supply chain risk register. Working capital trends (DPO, DIO, DSO). Customer-managed inventory or VMI programs.

Workforce, certifications, and quality systems. Headcount roster with tenure, comp, certifications, and 1099 vs W-2 status. Skilled retention rate over 24 months. Critical role bench depth. Wage rates vs local market benchmarks. Workforce age distribution. Current ISO 9001 / ISO 13485 / AS9100D / IATF 16949 / ITAR / CMMC 2.0 documentation. Audit findings and corrective actions over 24-36 months. Customer audit history. Supplier corrective action history (SCARs received). Process validation documentation. Calibration traceability. Environmental compliance: hazardous waste, air permits, wastewater. EPA / OSHA history. Phase 1 environmental site assessment.

The contract manufacturing sale process timeline: month by month

Contract manufacturing sale processes are longer than most manufacturing sub-verticals because diligence is more complex, customer reference calls are critical, and the value-added margin restatement requires careful presentation. $2M-$5M EBITDA deals run 9-12 months from launch to close. $5M-$15M EBITDA platform deals run 11-15 months. $15M+ EBITDA platforms can run 13-18 months because of QoE engagements, equipment appraisals, environmental Phase 1, customer reference calls with major OEMs (which require their schedule cooperation), R&W insurance underwriting, and ITAR transfer notifications if defense work is real.

Months 1-2: positioning and outreach. Build the CIM (35-60 pages, with value-added margin restatement front-and-center). Identify target buyer archetype mix. Reach out to industrial PE platforms (Audax, KKR Industrials, Cortec/Bromford, Trive, GenNx360, Wynnchurch), industry CMO consolidators (Jabil, Celestica, Sanmina, Flex, Kimball Electronics for electronics; Integer Holdings, Bel Fuse for medical; aerospace strategics for aerospace CMOs), regional consolidators, family offices with industrial mandates, and search funders with industry background. Sign NDAs with serious prospects. Target 10-20 serious initial conversations.

Months 2-4: management meetings and indications of interest. Take 5-10 buyer meetings. Industrial PE platforms send 2-3 person teams including operating partners with manufacturing expertise. Industry strategic acquirers bring engineering, operations, and customer-facing executives. Receive 3-7 indications of interest with non-binding price ranges. Negotiate to a single LOI, often with 2-3 finalist rounds for premium platforms.

Months 4-9: LOI, diligence, and financing. Sign LOI with 90-150 day exclusivity (longer for CMO because diligence is more complex). Buyer-side diligence: financial QoE ($80-200K cost for $5M+ EBITDA, with explicit value-added margin reconstruction); M&E equipment appraisal ($15-40K); customer reference calls with top customers (often the diligence bottleneck); supply chain audit; QMS audit by quality consultant; CMMC 2.0 readiness assessment if defense; environmental Phase 1; legal diligence on customer contracts and supplier agreements. Buyer financing: PE platforms have it lined up; strategic acquirers may use balance sheet cash.

Months 9-12: definitive agreement and close. Negotiate purchase agreement: working capital target (often $2-15M for CMOs given inventory levels), indemnification caps, R&W insurance for $5M+ EBITDA deals (common in CMO), environmental indemnity, non-compete (typically 5 years and broad geographic scope), seller employment / consulting agreement. Equipment FMV appraisal locks in asset allocation. ITAR transfer notification if applicable. Final walkthrough. Employee notification 24-72 hours pre-close. Customer notification per contract requirements. Major OEM notification per supplier-management requirements. Escrow funding. Signing.

Months 12+: transition. Post-close transition typically 90-180 days for $2M-$5M EBITDA deals, 120-240 days for platform deals. Seller often available for an additional 6-18 months. ITAR transfer completion if applicable. Certification continuity through ownership change (registrar notification required). Customer relationship transfer protocol — major OEMs require introduction to new ownership and confirmation of program continuity. Earnout periods if applicable run 12-36 months post-close.

Common mistakes contract manufacturing sellers make (and how to avoid them)

Mistake 1: ignoring customer concentration until diligence. Buyers will discover concentration in week 2 of diligence. Owners who haven’t addressed it look unprepared and force a re-trade. Address concentration 18-24 months before market through aggressive new-customer acquisition, end-market diversification, and (counterintuitively) intentional volume reduction with the concentrated customer. Document the diversification trend in your CIM proactively. On a $5M EBITDA business, moving from 50% top customer to 25% can be worth $5-10M in additional sale price.

Mistake 2: not separating value-added margin from pass-through revenue. CMOs that report only headline revenue and EBITDA force buyers to reconstruct value-added economics during diligence — which delays underwriting, signals operational immaturity, and often leads to lower offers. Restructure your income statement to separate pass-through material cost from value-added components 18+ months before market. Restate 24-36 months of historical financials in this format. Present value-added EBITDA as the primary metric in your CIM.

Mistake 3: under-investing in industry-specific certifications. A CMO with ISO 9001 only operating in medical device end market is leaving 1-1.5 turns of EBITDA on the table by not pursuing ISO 13485. Same for aerospace (AS9100D), automotive Tier 1/Tier 2 (IATF 16949), defense (ITAR + CMMC 2.0). The 12-18 month investment in industry-specific certifications typically returns 2-4x its cost at exit through multiple expansion.

Mistake 4: ignoring supply chain resilience documentation. Post-2020 buyers expect documented supply chain resilience. Sole-sourced critical inputs, single-region supply concentrations, and weak sub-tier qualification all compress multiple. The 12-18 month fix: identify top-10 critical inputs, qualify secondary suppliers, document qualification process, periodically test secondary suppliers with small production runs. Build a supply chain risk register. Buyers reward this work explicitly.

Mistake 5: hiring a generalist business broker. Contract manufacturing M&A is a specialist segment. Industrial PE platforms specifically active in CMO (Audax, KKR Industrials, Cortec/Bromford, Trive) have specific buy boxes around customer concentration, value-added margin, certifications, and end-market exposure. Industry CMO consolidators (Jabil, Celestica, Sanmina, Flex, Integer Holdings, Bel Fuse, Heico) have specific strategic theses around capability complement and customer overlap. A generalist broker who closed a restaurant last year doesn’t know who’s actively buying CMOs in your specific end-market exposure, doesn’t have the relationships, and runs a generic auction that signals inexperience.

Mistake 6: announcing the sale to key staff or critical customers too early. CMO deals are particularly vulnerable to information leakage. Key engineering and operations staff are highly portable. Major OEM customers are very sensitive to ownership change rumors and may dual-source preemptively. Wait until LOI signed (with retention bonuses for key staff if needed), then disclose strategically — usually within 30-60 days of close, with major OEM notification handled per supplier-management protocols, and retention bonuses paid at and after close.

How to position for the right contract manufacturing buyer archetype

Position for industrial PE platforms (Audax, KKR Industrials, Cortec/Bromford, Trive, GenNx360, Wynnchurch) when: You have $5M+ EBITDA, ISO 9001 minimum (industry-specific certs strongly preferred), diversified customer base (top customer below 30%), value-added margin separated from pass-through, supply chain resilience documented, real plant management, and willingness to roll equity 15-30%. Emphasize: certifications, customer diversification, value-added margin trend, supply chain resilience, end-market diversification, second-tier management, capex efficiency.

Position for industry CMO consolidators when: You have $5M+ EBITDA, full certification stack relevant to your end market (ISO 13485 for medical CMOs targeting Integer Holdings or Bel Fuse; AS9100D for aerospace CMOs targeting Heico or TransDigm; IPC certifications for electronics CMOs targeting Jabil, Celestica, Sanmina, Flex, Kimball Electronics, Benchmark, Plexus, Sparton). Emphasize: capability complement to acquirer’s existing platforms, customer overlap potential, geographic logic, end-market depth.

Position for regional CMO consolidators when: You have $1M-$5M EBITDA, capabilities complementary to the consolidator’s existing platforms, geographic fit, and willingness to integrate operations post-close. Emphasize: capability stack, geographic logic, customer overlap potential, ease of integration.

Position for family offices when: You have $2M-$10M EBITDA, longer-hold orientation makes sense, willing to roll meaningful equity (25-40%), and you value patient capital over maximum near-term cash. Emphasize: durability, customer relationship depth, multi-generational supply relationships, geographic moat.

Position for search funders (with industry background) when: You have $1M-$3M EBITDA, real second-tier team, established certifications, low-to-moderate customer concentration, growth runway, and an owner-replaceable role. Emphasize: defensibility, organic growth opportunity, manageable operational complexity. Search funders without CMO background struggle with the technical and customer-relationship complexity, so target searchers with industry background specifically.

Conclusion

Selling a contract manufacturing business in 2026 is a real opportunity — with one of the most active industrial PE buyer pools in lower middle market and meaningful strategic acquirer interest from industry CMO consolidators. But the multiples and outcomes diverge wildly based on customer concentration, value-added margin (vs pass-through revenue), certifications (ISO 13485, AS9100D, IATF 16949, ITAR + CMMC 2.0 by end market), supply chain resilience, end-market exposure, and which buyer archetype you target. Owners who succeed are the ones who stop benchmarking against generic manufacturing heuristics and start benchmarking against the actual 2026 contract manufacturing buyer pool: industrial PE platforms (Audax, KKR Industrials, Cortec/Bromford) paying 6-8x EBITDA on diversified value-added platforms; industry CMO consolidators paying 5.5-9x for capability-complementary acquisitions; regional consolidators paying 4.5-6x on bolt-ons; family offices paying 5-7x for patient-capital opportunities. Get your books clean 18-24 months ahead with value-added margin separated from pass-through. Diversify customer concentration aggressively. Pursue end-market-specific certifications. Document supply chain resilience. Build a real plant management team. Position for the right buyer archetype rather than running a generic auction. The owners who do this work see 30-50% better after-tax outcomes than the ones who go to market unprepared. And if you want to talk to someone who already knows the industrial PE and industry CMO consolidator buyers personally instead of running an auction, we’re a buy-side partner — the buyers pay us, not you, no contract required.

Frequently Asked Questions

What multiple should I expect when selling my contract manufacturing business in 2026?

Multiples vary by size and characteristics. $750K-$2M EBITDA: 4.5-6x. $2M-$5M EBITDA: 5-6.5x. $5M-$15M EBITDA: 5.5-7.5x. $15M+ platforms: 6.5-9x. End-market certifications add: ISO 13485 (medical) +1-1.5x; AS9100D (aerospace) +1-2x; IATF 16949 (automotive) +0.5-1x; ITAR + CMMC 2.0 (defense) +0.5-1x. Customer concentration above 30% subtracts 0.5-1.5 turns.

Who are the most active PE buyers of contract manufacturers in 2026?

Industrial PE platforms specifically active in CMO include Audax Private Equity industrial verticals (one of the most active CMO buyers in LMM PE), KKR Industrials, Cortec Group / Bromford Industries, Trive Capital, GenNx360, Wynnchurch Capital, Sterling Group industrial, and Industrial Growth Partners (IGP) selectively. Strategic CMO consolidators include Jabil, Celestica, Sanmina, Flex, Kimball Electronics for electronics; Integer Holdings, Bel Fuse, Phillips Medisize, Cretex Medical for medical; Heico, TransDigm, Senior Aerospace for aerospace.

Why is customer concentration the #1 issue in contract manufacturing valuation?

Contract manufacturing has structurally higher customer concentration than other manufacturing sub-verticals because the relationship economics support 5-15 major customers, not 200. Top-3 customers are often above 40%, and the top customer is frequently 25-50%. Buyers pro-forma concentration risk explicitly — a customer above 30% subtracts 0.5-1.5x EBITDA, and they’ll model 50-60% probability of churn over a 5-year hold for any concentrated customer. Address concentration 18-24 months before market.

What is the difference between pass-through revenue and value-added margin?

Contract manufacturing revenue typically includes 40-70% pass-through material cost (raw materials specified by the customer that flow through revenue with markup). Value-added revenue is gross revenue minus pass-through material. Value-added EBITDA margin is what buyers underwrite on, not headline EBITDA-to-revenue ratio. A $50M revenue / $5M EBITDA CMO with 70% pass-through is really a $15M value-added business with 33% value-added EBITDA margin — significantly different from a $50M revenue / $5M EBITDA CMO with 30% pass-through (14% value-added EBITDA margin).

How do industry-specific certifications affect my CMO sale price?

Significantly. ISO 13485 + FDA registration for medical device CMOs adds 1-1.5 turns. AS9100D + NADCAP for aerospace CMOs adds 1-2 turns. IATF 16949 for automotive Tier 1/Tier 2 CMOs adds 0.5-1 turn. ITAR + CMMC 2.0 for defense CMOs adds 0.5-1 turn. The 12-18 month investment in industry-specific certifications ($60-200K plus 12-18 months) typically returns 2-4x its cost at exit through multiple expansion.

Why is supply chain resilience now a buyer focus?

Post-2020 supply chain disruptions (COVID, semiconductor shortage, geopolitical tensions) have made buyers acutely aware of supply chain risk. CMOs with sole-sourced critical inputs, single-region supply concentrations, or weak sub-tier qualification are discounted by 0.25-0.5x EBITDA. The 12-18 month fix: identify top-10 critical inputs, qualify secondary suppliers, document qualification process, build a supply chain risk register, periodically test secondary suppliers.

How long does it take to sell a contract manufacturing business?

$2M-$5M EBITDA: 9-12 months. $5M-$15M EBITDA platform deals: 11-15 months. $15M+ platforms: 13-18 months. Diligence is more complex than other manufacturing sub-verticals because of customer reference calls (often the bottleneck), supply chain audit, value-added margin reconstruction, certification audits, and ITAR transfer notifications if defense work is real.

Should I implement an ERP / MES system before selling?

Yes, almost always for $2M+ EBITDA CMO. Modern ERP (SAP, Oracle NetSuite, Plex, IQMS, JobBOSS, Global Shop Solutions, Epicor) plus MES for real-time visibility typically returns 0.5-1x EBITDA at exit by enabling documented capacity utilization, OEE, customer-level profitability, and value-added margin reporting. Implementation cost: $200K-$1M plus 6-12 months. ROI is favorable on $2M+ EBITDA businesses.

How do I diversify customer concentration in a CMO?

Aggressive new-customer acquisition focused on adjacent end markets and applications. Intentional volume reduction with the concentrated customer (counterintuitive but materially improves multiple). New industry penetration. Capacity allocation toward new customers even at modestly lower margin in year 1-2 to build the diversified base. Document the diversification trend over 18-24 months in the CIM. Owners who execute this shift see 1-2 turns of EBITDA improvement on $5M EBITDA = $5-10M additional sale price.

Should I run a broker auction or do targeted outreach?

Targeted outreach almost always beats broad auction in CMO because the buyer pool is highly specialized. Industrial PE platforms specifically active in CMO (Audax, KKR Industrials, Cortec/Bromford) have specific buy boxes around customer concentration, value-added margin, certifications, and end-market exposure. Industry CMO consolidators (Jabil, Celestica, Integer Holdings, Heico) have specific strategic theses. Generic broker auctions burn relationships and signal inexperience to sophisticated specialty buyers.

What working capital should I expect to leave at close?

CMOs carry significant working capital tied up in inventory (raw, WIP, finished goods awaiting customer pull). Buyers expect normal operating working capital at close: typically 45-90 days of receivables minus 30-60 days of payables, plus inventory at normal operating levels. On a $50M revenue CMO, that’s typically $5-12M of value the seller leaves behind. Negotiate the working capital target during the LOI, not at close — many sellers don’t realize this until the final week.

How much seller financing or rollover equity should I expect?

Industrial PE platform deals: typically 0% seller note but 15-30% rollover equity (rollover is central to PE platform thesis for second-bite economics). Industry CMO consolidator deals: typically cash-heavy with selective earnout for customer retention. Regional consolidator deals: 10-20% seller note common. Family office deals: 25-40% rollover equity common. Refusing rollover equity on PE platform deals typically reduces multiple by 0.5-1x.

How is CT Acquisitions different from a sell-side broker or M&A advisor?

We’re a buy-side partner, not a sell-side broker. Sell-side brokers represent you and charge you 8-12% of the deal (often $1-5M+ on CMO platforms) plus monthly retainers, run a 12-15 month auction process, and require 12-month exclusivity. We work directly with 76+ buyers — including 38 actively pursuing manufacturing, with industrial PE platforms specifically active in CMO (Audax, KKR Industrials, Cortec/Bromford, Trive, GenNx360, Wynnchurch), industry CMO consolidators (Jabil, Celestica, Sanmina, Flex, Integer Holdings, Bel Fuse, Heico), regional consolidators, family offices with industrial mandates, and search funders with industry background — who pay us when a deal closes. You pay nothing. No retainer, no exclusivity, no contract until a buyer is at the closing table. We move faster (90-180 days from intro to close) because we already know who the right buyer is rather than running an auction to find one.

Sources & References

All claims and figures in this analysis are sourced from the publicly available references below.

1. U.S. Small Business Administration: 7(a) Loan Program
2. National Association of Manufacturers (NAM): Contract Manufacturing Data
3. ISO 13485 Medical Devices Quality Management
4. AS9100 / SAE International Aerospace Standards
5. IATF 16949 Automotive Quality Management Standard
6. DoD: CMMC 2.0 Cybersecurity Maturity Model Certification
7. Audax Private Equity Industrial Investments
8. KKR Industrials Sector